STAT6 EXPRESSION BY PERIPHERAL BLOOD LYMPHOCYTES IN BRONCHIAL ASTHMA
https://doi.org/10.15789/1563-0625-2007-4-5-405-410
Abstract
Abstract. The aim of present study was to determine the features of STAT6 and phospho-STAT6 (pSTAT6) expression in bronchial asthma (BA). Patients and methods. Eleven patients with allergic (atopic) steroidfree were examined, five healthy controls served as a control. Expression of proteins (STAT6 and pSTAT6) in peripheral blood lymphocytes was studied by Western blot analysis after cell lysis. Preparation of cell lysates and Western blotting were performed using a standard procedure (Amersham). Antibodies against pSTAT6 and STAT6 (manufactured by Cell Signaling) were used. Relative levels of specific proteins were analyzed using actin as a reference, by means of anti-actin antibody. Results. STAT6 phosphorylation was significantly increased in lymphocytes of patients with BA exacerbation, as compared to patients in remission and healthy group. The level of STAT6 was significantly higher compared to healthy persons and showed negative correlation with grade of air flow obstruction. Conclusion. STAT6 and their active form pSTAT6 may play a key role in BA pathophysiology. This study suggests atopic, steroid-free BA (in particular, on exacerbation) to be associated with active cellular inflammatory process, involving activation of STAT6, along with increased level of their active form (pSTAT6). The work was supported by Saint-Petersburg government grants: PD04-4.0-102 (Certificate N ASP604079).
About the Authors
V. N. Mineev
Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова, Санкт-Петербург
Russian Federation
Russian Federation
L. N. Sorokina
Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова, Санкт-Петербург
Russian Federation
Russian Federation
References
1. Минеев В.Н., Нестерович И.И., Лалаева Т.М., Иванова В.В., Яблонская В.Н., Булатова Н.Ю., Лукашевская Н.Н., Сорокина Л.Н., Рабик Ю.Д., Супранович И.Ю., Волченкова О.С., Болотина Н.В. Сигнальные системы при бронхиальной астме // Ученые записки СПбГМУ им. акад. И.П. Павлова. – 2001. – Т. 8, № 1. – С. 17-21.
2. Минеев В.Н., Сорокина Л.Н. Современные представления о JAK-STAT системе как новой сигнальной системе и ее нарушениях при иммунной патологии. Часть I // Аллергология. – 2005. – № 4. – С. 38-44.
3. Минеев В.Н., Сорокина Л.Н. Современные представления о JAK-STAT системе как новой сигнальной системе и ее нарушениях при иммунной патологии: механизмы негативной регуляции. Часть II // Аллергология. – 2006. – № 1. – С. 49-55.
4. Фрейдлин И.С., Тотолян А.А. Иммунологические механизмы аллергических реакций // Общая аллергология / Под ред. Г.Б. Федосеева. – СПб.: Нордмедиздат, 2001. – Т. 1. – С. 169-381.
5. Christodoulopoulos P., Cameron L., Nakamura Y., Lemière C., Muro S., Dugas M., Boulet L-P., Laviolette M., Olivenstein R., Hamid Q. Th2-cytokine-associated transcription factors in atopic and nonatopic asthma: evidence for differential signal transducer and activator of transcription 6 expression // J. Allergy Clin. Immunol. – 2001. – Vol. 107, N 4. – P. 586-591.
6. Chung K.F., Barnes P.J. Cytokines in asthma // Thorax. – 1999. – Vol. 54. – P. 825-857.
7. Kaplan M.H., Schindler U., Smiley S.T., Grusby M.J. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells // Immunity. – 1996. – Vol. 4. – P. 313-319.
8. Kile B.T., Schulman B.A., Alexander W.S., Nicola N.A., Martin H.M., Hilton D.J. The SOCS box: a tale of destruction and degradation // Trends Biochem. Sci. – 2002. – Vol. 27. – P. 235-241.
9. Kuperman D., Schofield B., Wills-Karp M., Grusby M.J. Signal transducer and activator of transcription factor 6 (Stat-6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production // J. Exp.Med. – 1998. – Vol. 187. – P. 939-948.
10. Losman J.A., Chen X.P., Hilton D., Rothman P. Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction // J. Immunol. – 1999. – Vol. 162. – P. 3770-3774.
11. Miller R.L., Eppinger T.M., McConnell D., Cunninham-Rundles C., Rothman P. Analysis of cytokine signaling in patients with extrinsic asthma and hyperimmunoglobulin E // J. Allergy Clin. Innunol. – 1998. – Vol. 102. – P. 503-511.
12. Mullings, R.E., Wilson S.J., Puddicombe S.M., Lordan J.L., Bucchieri F., Djukanovi R., Howarth P.H., Harper S., Holgate S.T., Davies D.E. Signal transducer and activator of transcription 6 (Stat-6) expression and function in asthmatic bronchial epithelium // J. Allergy Clin. Immunol. – 2001. – Vol. 108, N 5. – P. 832-838.
13. Murray P.J. The JAK-STAT signaling pathway: input and output integration // J. Immunol. – 2007. – Vol. 178. – P. 2623-2629.
14. O’Shea J.J., Park H., Pesu M., Borie D., Changelian P. New strategies for immunosuppression: interfering with cytokines by targeting the Jak/Stat pathway // Curr. Opin. Rheumatol. – 2005. – Vol. 17, N 3. – P. 305-311.
15. Pernis A.B., Rothman P.B. JAK-STAT signaling in asthma // J. Clin. Invest. – 2002. – Vol. 109, N 10. – P. 1279-1283.
16. Rawlings J.S., Rosler K.M., Harrison D.A. The JAK-STAT signaling pathway // J. Cell Science. – 2004. – Vol. 117. – P. 1281-1283.
17. Schindler C.W. JAK-STAT signaling in human disease // J. Clin. Invest. – 2002. – Vol. 109. – P. 1133-1137.
18. Shuai K., Liu B. Regulation of JAK-STAT signaling in the immune system // Nature. – 2003. – Vol. 3. – P. 900-911.
19. Tomkinson A., Kanehiro A., Rabinovitch N., Joetham A., Cieslewicz G., Gelfand E.W. The failure of STAT6-deficient mice to develop airway eosinophilia and airway hyperresponsiveness is overcome by interleukin-5 // Am. J. Respir. Crit. Care Med. – 1999. – Vol. 160. – P. 1283-1291.
Review
For citations:
Mineev V.N., Sorokina L.N. STAT6 EXPRESSION BY PERIPHERAL BLOOD LYMPHOCYTES IN BRONCHIAL ASTHMA. Medical Immunology (Russia). 2007;9(4-5):405-410. (In Russ.) https://doi.org/10.15789/1563-0625-2007-4-5-405-410
Views:
918
Email this article 